Ozempic’s Maker Got Crushed. The Rebound Is Under Way.
PositiveFinancial Markets

Novo Nordisk, the maker of Ozempic, is showing signs of recovery after facing challenges. With a new weight-loss pill on the way and the FDA indicating a stricter approach to compounded knockoffs, the company may be on the verge of a turnaround. This is significant as it highlights the potential for innovation in weight management solutions and the importance of regulatory support in ensuring market integrity.
— Curated by the World Pulse Now AI Editorial System